AP611074 5% Gel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AP611074 5% Gel, covering 2018-07-20 to 2018-07-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients [Phase 2]